Psychopharmacology

, Volume 173, Issue 3–4, pp 440–445

Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety

Original Investigation

Abstract

Rationale

The effects of MDMA on driving behaviour are not clear, since the direct effects of MDMA on cognitive performance are reported as not generally negative.

Objectives

To assess in an advanced driving simulator acute effects on simulated driving behaviour and heart rate of MDMA, and effects of polydrug use.

Methods

A group of young participants who had indicated that they regularly used MDMA were asked to complete test rides in an advanced driving simulator, shortly after the use of MDMA, just before going to a party. They were tested again after having visited the “rave”, while they were under the influence of MDMA and a number of different other active drugs. Participants were also tested sober, at a comparable time at night. Separately, a control group of participants was included in the experiment.

Results

Driving performance in the sense of lateral and longitudinal vehicle control was not greatly affected after MDMA, but deteriorated after multiple drug use. The most striking result was the apparent decreased sense for risk taking, both after MDMA and after multiple drug use. This was clear from gap acceptance data, while the ultimate indicator of unsafe driving, accident involvement or even causation, was increased by 100% and 150%, respectively.

Conclusions

Driving under the influence of MDMA alone is certainly not safe; however, driving back (home) after a dance party (“rave”) where MDMA users regularly combine MDMA with a host of other drugs can be described as extremely dangerous.

Keywords

Ecstasy MDMA Safety Driving Cognitive performance 

References

  1. Backs RW, Seljos KA (1994) Metabolic and cardiorespiratory measures of mental effort: the effects of level of difficulty in a working memory task. Int J Psychophysiol 16:57–68CrossRefPubMedGoogle Scholar
  2. Brookhuis KA, De Vries G, Prins van Wijngaarden P, Veenstra, G, Hommes, M, Louwerens, JW, O’Hanlon, JF (1985) The effects of increasing doses of meptazinol (100, 200, 400 mg) and glafenine (200 mg) on driving performance. Traffic Research Centre, University of Groningen, Haren, The NetherlandsGoogle Scholar
  3. Brookhuis KA, Volkerts ER, O’Hanlon JF (1990) Repeated dose effects of lormetazepam and flurazepam upon driving performance. Eur J Clin Pharmacol 39:83–87PubMedGoogle Scholar
  4. Brookhuis KA, De Vries G, De Waard D (1993) Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance. Br J Clin Pharmacol 36:67–70PubMedGoogle Scholar
  5. Brookhuis KA, De Waard D, Mulder LJM (1994) Measuring driving performance by car-following in traffic. Ergonomics 37:427–434Google Scholar
  6. Davison D, Parrott AC (1997) Ecstasy (MDMA) in recreational users: self-reported psychological and physiological effects. Hum Psychopharmacol 12:221–226Google Scholar
  7. De Waard D, Brookhuis KA (2000) Drug effects on driving performance, letter to the editor. Ann Int Med 133:656–657Google Scholar
  8. De Waard D, Van Der Hulst M, Brookhuis KA (1999a) Elderly and young drivers’ reaction to an in-car enforcement and tutoring system. Appl Ergonom 30:147–157CrossRefGoogle Scholar
  9. De Waard D, Van der Hulst M, Hoedemaeker M, Brookhuis KA (1999b) Reply to comments on “Driver behavior in an emergency situation in the Automated Highway System”. Transport Hum Fact 1:87–89Google Scholar
  10. Fergusson DM, Horwood LJ (2001) Cannabis use and traffic accidents in a birth cohort young adults. Accident Anal Prevent 33:703–711CrossRefGoogle Scholar
  11. Horwood LJ, Fergusson DM (2000) Drink driving and traffic accidents in young people. Accident Anal Prevent 32:805–814CrossRefGoogle Scholar
  12. Kramer AF (1991) Physiological metrics of mental workload: a review of recent progress. In: Damos DL (ed) Multiple-task performance. Taylor and Francis, London, pp 279–328Google Scholar
  13. Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR (1992) Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? Am J Drug Alcohol Abuse 18:331–341PubMedGoogle Scholar
  14. Logan BK, Couper FJ (2001) 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment. J Forens Sci 46:1426–1433Google Scholar
  15. Michon JA (1985) A critical view of driver behavior models: what do we know, what should we do? In: Evans L, Schwing RC (eds) Human behavior and traffic safety. Plenum Press, New York, pp 485–524Google Scholar
  16. Morgan MJ (1998) Recreational use of “ecstasy” (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252–264CrossRefPubMedGoogle Scholar
  17. Morgan MJ (2000) Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 152:230–248PubMedGoogle Scholar
  18. Mulder LJM (1992) Measurement and analysis methods of heart rate and respiration for use in applied environments. Biol Psychol 34:205–236PubMedGoogle Scholar
  19. Mulder LJM, De Waard D., Brookhuis K.A. (2003) Estimating mental effort using heart rate and heart rate variability. In: Stanton N, Hedge A, Hendrick HW, Brookhuis KA, Salas E (eds) Handbook of ergonomics and human factors methods. Taylor and Francis, LondonGoogle Scholar
  20. Parrot AC, Larsky J (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology 139:261–268CrossRefPubMedGoogle Scholar
  21. Parrott AC, Stuart M (1997) Ecstasy (MDMA), amphetamine, and LSD: comparative mood profiles in recreational polydrug users. Hum Psychopharmacol 12:501–504CrossRefGoogle Scholar
  22. Rodgers J (2000) Cognitive performance amongst recreational users of “ecstasy”. Psychopharmacology 151:19–24PubMedGoogle Scholar
  23. Samyn N, Verstraete A, Van Haeren C, Kintz P (1999) Analysis of drugs of abuse in saliva. Forens Sci Rev 11:1–19Google Scholar
  24. Samyn N, De Boeck G, Wood M, Lamers, CTJ, De Waard, D, Brookhuis, KA, Verstraete, AG, Riedel, WJ (2002) Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forens Sci Int 128:90–97CrossRefGoogle Scholar
  25. Schifano F (1995) Dangerous driving and MDMA (“Ecstasy”) abuse. J Seroton Res 1:53–57Google Scholar
  26. Van Roon AM (1998) Short-term cardiovascular effects of mental tasks. Physiology, experiments and computer simulation. PhD Thesis, University of Groningen, Groningen, The NetherlandsGoogle Scholar
  27. Van Wolffelaar PC, Van Winsum W (1995) Traffic simulation and driving simulation—an integrated approach. In: Proceedings of the Driving Simulator Conference (DSC ‘95). Teknea, Toulouse, FranceGoogle Scholar
  28. Verkes RJ, Gijsman H, Pieters MSM, Schoemaker RC, De Visser S, Kuijpers M, Pennings EJM, Van Gerven JMA, Cohen AF (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153:196–202PubMedGoogle Scholar
  29. Vollenweider FX, Gamma A, Liechti M, Huber T (1998) Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naive healthy volunteers. Neuropsychopharmacology 19:241–251CrossRefPubMedGoogle Scholar
  30. Zijlstra FRH (1993) Efficiency in work behavior. A design approach for modern tools. PhD thesis, Delft University of Technology, Delft. Delft University Press, The Netherlands.Google Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Karel A. Brookhuis
    • 1
  • Dick de Waard
    • 1
  • Nele Samyn
    • 2
  1. 1.Department of PsychologyUniversity of GroningenGroningenThe Netherlands
  2. 2.Drugs and Toxicology, Section on ToxicologyNational Institute of Criminalistics and CriminologyBrusselsBelgium

Personalised recommendations